CBC Group es­tab­lish­es new fund to meet Chi­na's boom­ing life sci­ences re­al es­tate de­mand

De­mand for life sci­ence re­al es­tate is surg­ing in Chi­na — and one of Asia’s largest in­vest­ment groups is ris­ing to the call.

CBC Group — the start­up en­gine that re­cent­ly lured in Mer­ck’s for­mer R&D chief Roger Perl­mut­ter — is join­ing forces with Nether­lands Pen­sion provider APG As­set Man­age­ment to launch a new Asia-Pa­cif­ic health­care plat­form and Chi­na-fo­cused life sci­ence ven­ture.

The fund, dubbed CBC Chi­na Life Sci­ence In­fra­struc­ture Ven­ture (CLSIV), com­plet­ed a first close of $500 mil­lion to pro­vide “best-in-class fa­cil­i­ties” for re­search in Chi­na. CBC de­scribes it as the ve­hi­cle by which the plat­form, CBC Health­care In­fra­struc­ture Plat­form (CBC HIP), will op­er­ate.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER